Scale -

  • Revenue is 829 Rs Cr; Annual Growth is 21 %; Continuous Growth over 3 years; in Top Quartile
  • Ebitda is 279 Rs Cr; Annual Growth is 36 %; Continuous Growth over 3 years; in Top Quartile
  • PBT is 67.58 Rs Cr; Annual Growth is 44 %; Continuous Growth over 3 years; in Top Quartile
  • PAT is 161 Rs Cr; Annual Growth is 75 %; Continuous Growth over 3 years; in Top Quartile
  • Quarterly Revenue is 240 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -

  • PBDIT Margin is 33.65 %; Annual Growth is 13 %; Continuous Growth over 3 years; in Top Quartile
  • PAT Margin is 19.47 %; Annual Growth is 45 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is -10 %
  • Quarterly Ebitda Margin is 32 %; in Top Quartile
  • Quarterly Profit margin is 21 %; in Top Quartile

Return -

  • ROCE is 34.59 %; Annual Growth is 32 %; Continuous Growth over 3 years; in Top Quartile
  • ROA is 21.81 %; Annual Growth is 65 %; Continuous Growth over 3 years; in Top Quartile
  • ROE is 27.84 %; Annual Growth is 66 %; Continuous Growth over 3 years; in Top Quartile
  • Asset Turnover is 115 %; Continuous Growth over 3 years; in Top Quartile

Efficiency -

  • Inventory Turnover Ratio is 17.45; Continuous Growth over 3 years; 5 Year CAGR is 27 %
  • Operating cash flow is 213 Rs Cr; Continuous Growth over 3 years; in Top Quartile

Solvancy -

  • Debt/Equity is 0; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile
  • Contingent Liabilities is 242 Rs Cr; in Top Quartile

Quality -

  • Current Tax/PAT is 35 %; Annual Decline is -32 %; in Top Quartile
  • Change in Inventories/Total Expenses is 0 %; Annual Decline is -125 %; in Bottom Quartile
  • Operating cashflow/ebitda is 76 %; in Top Quartile; 5 Year CAGR is 16 %; Continuous Decline over 3 years
  • Exceptional Items/PBT is -3 %; in Bottom Quartile
  • Operating cashflow/PAT is 132 %; 5 Year CAGR is 20 %; Annual Decline is -36 %; Continuous Decline over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Buy Thyrocare Technologies; target of Rs 620: ICICI Securities
Read More
  • Past/current
Thyrocare Q2 FY27 Revenue Rises 25.1%
Read More
  • Past/current
Thyrocare Revenue Up 25% in Q2; Profit Hit by ?45 Cr Impairment
Read More
  • Past/current
Thyrocare Technologies Limited reports revenue of INR 270.8 Cr in Q2 FY27, with a growth of 25.1% YoY
Read More
  • Past/current
Thyrocare Technologies Q2 FY27 Results Newspaper Publication
Read More
  • Past/current
Thyrocare Technologies: Sells Entire Stake in Nueclear Healthcare for ?1414 Crore
Read More
  • Past/current
Why Did Thyrocare Technologies Shares Crash 9% Today? Here’s What You Need to Know
Read More
  • Past/current
Thyrocare Q2 results: Profit falls as impairment charge weighs on earnings
Read More
  • Past/current
Thyrocare Q2FY27 Results: Revenue Up 25.1%, PAT Rises 25.7%
Read More
  • Past/current
Thyrocare Q2FY27 Results: Standalone revenue up 25%, net profit dips on impairment
Read More
  • Past/current
Thyrocare Reports ?270.8 Crore Revenue For Q2 FY27, PAT Before Exceptional Items At ?60.2 Crore
Read More
  • Past/current
Thyrocare Technologies Ltd (BOM:539871) (Q2 2027) Earnings Call
Read More
  • Past/current
Thyrocare: Q2 FY27 Earnings Presentation Released
Read More
  • Past/current
Thyrocare: Q2 FY27 Financial Results Released
Read More
  • Past/current
Thyrocare: Q2 FY27 Revenue Jumps 25.1% to ?270.8 Crore
Read More
  • Past/current
PharmEasy exploring merger with diagnostic unit Thyrocare
Read More
  • Past/current
Thyrocare Technologies (BSE:539871)
Read More
  • Past/current
Thyrocare Technologies (NSEI:THYROCARE)
Read More
  • Past/current
Thyrocare Technologies Ltd recommends final dividend of Rs 7.00 per share for FY26
Read More
  • Past/current